These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8605949)

  • 1. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats.
    Hajri T; Férézou J; Laruelle C; Lutton C
    Eur J Pharmacol; 1995 Nov; 286(2):131-6. PubMed ID: 8605949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Hajri T; Chanussot F; Férézou J; Riottot M; Lafont H; Laruelle C; Lutton C
    Eur J Pharmacol; 1997 Feb; 320(1):65-71. PubMed ID: 9049604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action in the liver of crilvastatin, a new hydroxymethylglutaryl-coenzyme A reductase inhibitor.
    Clerc T; Jomier M; Chautan M; Portugal H; Senft M; Pauli AM; Laruelle C; Morel O; Lafont H; Chanussot F
    Eur J Pharmacol; 1993 Apr; 235(1):59-68. PubMed ID: 8519281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Fears R; Richards DH; Ferres H
    Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol metabolism in the genetically hypercholesterolemic rat (RICO). I. Measurement of turnover processes.
    Cardona-Sanclemente LE; Verneau C; Mathe D; Lutton C
    Biochim Biophys Acta; 1987 Jun; 919(3):205-12. PubMed ID: 3297166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes.
    Clerc T; Sbarra V; Diaconescu N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1995 Feb; 114(3):624-31. PubMed ID: 7735689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats.
    Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R
    Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat.
    Batta AK; Xu G; Honda A; Miyazaki T; Salen G
    Metabolism; 2006 Mar; 55(3):292-9. PubMed ID: 16483871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells.
    Jesch ED; Seo JM; Carr TP; Lee JY
    Nutr Res; 2009 Dec; 29(12):859-66. PubMed ID: 19963159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase modulator: toward age- and sex-personalized medicine.
    Pallottini V
    Expert Opin Ther Pat; 2015; 25(10):1079-83. PubMed ID: 26135220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical heterogeneity of the intestinal mucosa and cholesterol homeostasis. A review of studies with normal and genetically hypercholesterolemic (RICO) Rat.
    Lutton C
    Digestion; 1996; 57(1):1-10. PubMed ID: 8626041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocholesterolemic effect of physically refined rice bran oil: studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters.
    Ausman LM; Rong N; Nicolosi RJ
    J Nutr Biochem; 2005 Sep; 16(9):521-9. PubMed ID: 16115540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
    Clerc T; Sbarra V; Domingo N; Rault JP; Diaconescu N; Moutardier V; Hasselot N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1996 Aug; 118(7):1862-8. PubMed ID: 8842455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs.
    Kwong LK; Feingold KR; Peric-Golia L; Le T; Karkas JD; Alberts AW; Wilson DE
    Diabetes; 1991 Dec; 40(12):1630-9. PubMed ID: 1756903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.